Bioassay at Uranium Mills, 35387-35388 [2014-14452]

Download as PDF 35387 Federal Register / Vol. 79, No. 119 / Friday, June 20, 2014 / Notices The information concerning this export license amendment application follows. NRC EXPORT LICENSE AMENDMENT APPLICATION Name of applicant, date of application, date received, Application No., Docket No. Cambridge Isotope Laboratories, Inc., May 30, 2014, June 4, 2014, XMAT426/ 01, 11006063. Description of material Material type Deuterium gas, deuterium oxide, and deuterium compounds. For the Nuclear Regulatory Commission. Dated this 11th day of June 2014 in Rockville, Maryland. Michael J. Case, Acting Deputy Director, Office of International Programs. [FR Doc. 2014–14495 Filed 6–19–14; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2012–0057] Bioassay at Uranium Mills Nuclear Regulatory Commission. ACTION: Regulatory guide; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing a revision to Regulatory Guide (RG) 8.22, ‘‘Bioassay at Uranium Mills.’’ This guide describes a bioassay program acceptable to the NRC staff for uranium mills and applicable portions of uranium conversion facilities where the possibility of exposure to yellowcake dust exists. ADDRESSES: Please refer to Docket ID NRC–2012–0057 when contacting the NRC about the availability of information regarding this document. You may access publicly-available information related to this action by the following methods: • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC–2012–0057. Address questions about NRC dockets to Carol Gallagher; telephone: 301–287–3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at http://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 22:31 Jun 19, 2014 Total quantity Jkt 232001 End use Recipient country 10,000 kgs .......................... Non-nuclear end-use in medical, pharmaceutical, chemical, and industrial markets. United Arab Emirates. then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced in this notice (if that document is available in ADAMS) is provided the first time that a document is referenced. Revision 2 of RG 8.22 is available in ADAMS under Accession No. ML13350A638. The regulatory analysis may be found in ADAMS under Accession No. ML110960341. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. FOR FURTHER INFORMATION CONTACT: Harriet Karagiannis, telephone: 301– 251–7477, email: Harriet.Karagiannis@ nrc.gov; or Casper Sun, telephone: 301– 251–7912; email: Casper.Sun@nrc.gov. Both of the Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. SUPPLEMENTARY INFORMATION: I. Introduction The NRC is issuing a revision to an existing guide in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public information such as methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. The NRC issued Revision 2 of RG 8.22 for public comment with a temporary identification as draft regulatory guide (DG), DG–8051. This guide describes a PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 method that the NRC staff considers acceptable for complying with the Commission’s regulations concerning bioassay at uranium mills. It provides methods that the NRC staff considers acceptable to implement Part 20 of Title 10 of the Code of Federal Regulations, (10 CFR), ‘‘Standards for Protection Against Radiation.’’ II. Additional Information Draft Regulatory Guide, DG–8051, was published in the Federal Register on March 13, 2012 (77 FRN 14837), for a 60-day public comment period. The public comment period closed on May 11, 2012. Public comments on DG–8051 and the NRC staff’s responses to the public comments are available in ADAMS under Accession No. ML13350A639. The NRC revised this guide for a better alignment with: (1) 10 CFR Part 20; (2) the internal dose assessment recommended by the International Commission on Radiological Protection (ICRP), Publication 30, ‘‘Limits for Intakes of Radionuclides by Workers’’; and (3) the recommended bioassay interpretation method by ICRP Publication 54, ‘‘Individual Monitoring for Intakes of Radionuclides by Workers: Design and Interpretation.’’ Regulatory Guide, 8.22, Revision 2 also provides: (1) Recommendations based on the nephrotoxic analyses in NUREG–0874, ‘‘Internal Dosimetry Model for Applications to Bioassay at Uranium Mills,’’ (Appendix A of the guide); and (2) the consensus standard of the American National Standards Institute/Health Physics Society (ANSI/ HPS) N13.30–2011, ‘‘Performance Criteria for Radiobioassay,’’ that is applicable for uranium mills. III. Congressional Review Act This RG is a rule as defined in the Congressional Review Act (5 U.S.C. 801–808). However, the Office of Management and Budget has not found it to be a major rule as defined in the Congressional Review Act. E:\FR\FM\20JNN1.SGM 20JNN1 35388 Federal Register / Vol. 79, No. 119 / Friday, June 20, 2014 / Notices IV. Backfitting and Issue Finality Issuance of this final RG does not constitute backfitting as defined in 10 CFR 50.109, 70.76, 72.62, or 76.76 and is not otherwise inconsistent with the issue finality provisions in 10 CFR Part 52, ‘‘Licenses, Certifications, and Approvals for Nuclear Power Plants.’’ This final RG provides guidance to applicants for, and holders of, uranium milling licenses and some uranium conversion facility licenses on methods for meeting certain NRC regulatory requirements for bioassays in 10 CFR Part 20. Licensees may voluntarily use RG 8.22, Revision 2 to demonstrate compliance with the underlying NRC’s regulations. Dated at Rockville, Maryland, this 17th day of June, 2014. For the Nuclear Regulatory Commission. Thomas H. Boyce, Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2014–14452 Filed 6–19–14; 8:45 am] BILLING CODE 7590–01–P PENSION BENEFIT GUARANTY CORPORATION Proposed Submission of Information Collection for OMB Review; Comment Request; Disclosure of Termination Information Pension Benefit Guaranty Corporation. ACTION: Notice of intent to request extension of OMB approval. AGENCY: Pension Benefit Guaranty Corporation (‘‘PBGC’’) intends to request that the Office of Management and Budget (‘‘OMB’’) extend approval, under the Paperwork Reduction Act of 1995, of a collection of information on the disclosure of termination information under its regulations for distress terminations, 29 CFR part 4041, Subpart C, and for PBGC-initiated terminations under 29 CFR part 4042 (OMB control number 1212–0065; expires September 30, 2014). This notice informs the public of PBGC’s intent and solicits public comment on the collection of information. DATES: Comments should be submitted by August 19, 2014. ADDRESSES: Comments may be submitted by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the Web site instructions for submitting comments. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 22:31 Jun 19, 2014 Jkt 232001 • Email: paperwork.comments@ pbgc.gov. • Fax: 202–326–4224. • Mail or Hand Delivery: Legislative and Regulatory Department, Pension Benefit Guaranty Corporation, 1200 K Street NW., Washington, DC 20005– 4026. PBGC will make all comments available on its Web site at www.pbgc.gov. Copies of the collection of information may be obtained without charge by writing to the Disclosure Division of the Office of the General Counsel of PBGC at the above address, visiting the Disclosure Division, faxing a request to 202–326–4042, or calling 202–326–4040 during normal business hours. (TTY and TDD users may call the Federal relay service toll-free at 1–800– 877–8339 and ask to be connected to 202–326–4040.) The regulations and instructions relating to this collection of information are available on PBGC’s Web site at www.pbgc.gov. FOR FURTHER INFORMATION CONTACT: Jo Amato Burns, Attorney, Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street, NW., Washington, DC 20005, 202–326– 4024. (For TTY and TDD, call 800–877– 8339 and ask to be connected to 202– 326–4024.) SUPPLEMENTARY INFORMATION: Sections 4041 and 4042 of the Employee Retirement Income Security Act of 1974, as amended (‘‘ERISA’’), 29 U.S.C 1301– 1461, govern the termination of singleemployer defined benefit pension plans that are subject to Title IV of ERISA. A plan administrator may initiate a distress termination pursuant to section 4041(c), and PBGC may itself initiate proceedings to terminate a pension plan under section 4042 if PBGC determines that certain conditions are present. Section 506 of the Pension Protection Act of 2006 amended sections 4041 and 4042 of ERISA. These amendments require that, upon a request by an affected party, a plan administrator must disclose information it has submitted to PBGC in connection with a distress termination filing, and that a plan administrator or plan sponsor must disclose information it has submitted to PBGC in connection with a PBGCinitiated termination. The provisions also require PBGC to disclose the administrative record relating to a PBGC-initiated termination upon request by an affected party. A description of the current disclosure provisions for distress terminations can be found on PBGC’s Web site at www.pbgc.gov/Documents/ PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Disclosure_of_Distress_Termination_ Information.pdf. PBGC estimates that three participants or other affected parties will annually make requests for termination information. PBGC estimates that the total annual burden for the collection of information will be about 45 hours and $900 (15 hours and $300 per request). PBGC is soliciting public comments to— • Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Issued in Washington, DC, this 16th day of June, 2014. Judith Starr, General Counsel, Pension Benefit Guaranty Corporation. [FR Doc. 2014–14462 Filed 6–19–14; 8:45 am] BILLING CODE 7709–02–P POSTAL REGULATORY COMMISSION [Docket Nos. MC2014–27 and CP2014–53; Order No. 2092] New Postal Product Postal Regulatory Commission. Notice. AGENCY: ACTION: The Commission is noticing a recent Postal Service filing requesting the addition of Priority Mail Express, Priority Mail & First-Class Package Service Contract 3 to the competitive product list. This notice informs the public of the filing, invites public comment, and takes other administrative steps. DATES: Comments are due: June 24, 2014. ADDRESSES: Submit comments electronically via the Commission’s Filing Online system at http:// www.prc.gov. Those who cannot submit comments electronically should contact the person identified in the FOR FURTHER INFORMATION CONTACT section by SUMMARY: E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 79, Number 119 (Friday, June 20, 2014)]
[Notices]
[Pages 35387-35388]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14452]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2012-0057]


Bioassay at Uranium Mills

AGENCY: Nuclear Regulatory Commission.

ACTION: Regulatory guide; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing a 
revision to Regulatory Guide (RG) 8.22, ``Bioassay at Uranium Mills.'' 
This guide describes a bioassay program acceptable to the NRC staff for 
uranium mills and applicable portions of uranium conversion facilities 
where the possibility of exposure to yellowcake dust exists.

ADDRESSES: Please refer to Docket ID NRC-2012-0057 when contacting the 
NRC about the availability of information regarding this document. You 
may access publicly-available information related to this action by the 
following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2012-0057. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at http://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number 
for each document referenced in this notice (if that document is 
available in ADAMS) is provided the first time that a document is 
referenced. Revision 2 of RG 8.22 is available in ADAMS under Accession 
No. ML13350A638. The regulatory analysis may be found in ADAMS under 
Accession No. ML110960341.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
    Regulatory guides are not copyrighted, and NRC approval is not 
required to reproduce them.

FOR FURTHER INFORMATION CONTACT: Harriet Karagiannis, telephone: 301-
251-7477, email: Harriet.Karagiannis@nrc.gov; or Casper Sun, telephone: 
301-251-7912; email: Casper.Sun@nrc.gov. Both of the Office of Nuclear 
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001.

SUPPLEMENTARY INFORMATION:

I. Introduction

    The NRC is issuing a revision to an existing guide in the NRC's 
``Regulatory Guide'' series. This series was developed to describe and 
make available to the public information such as methods that are 
acceptable to the NRC staff for implementing specific parts of the 
agency's regulations, techniques that the staff uses in evaluating 
specific problems or postulated accidents, and data that the staff 
needs in its review of applications for permits and licenses.
    The NRC issued Revision 2 of RG 8.22 for public comment with a 
temporary identification as draft regulatory guide (DG), DG-8051. This 
guide describes a method that the NRC staff considers acceptable for 
complying with the Commission's regulations concerning bioassay at 
uranium mills. It provides methods that the NRC staff considers 
acceptable to implement Part 20 of Title 10 of the Code of Federal 
Regulations, (10 CFR), ``Standards for Protection Against Radiation.''

II. Additional Information

    Draft Regulatory Guide, DG-8051, was published in the Federal 
Register on March 13, 2012 (77 FRN 14837), for a 60-day public comment 
period. The public comment period closed on May 11, 2012. Public 
comments on DG-8051 and the NRC staff's responses to the public 
comments are available in ADAMS under Accession No. ML13350A639.
    The NRC revised this guide for a better alignment with: (1) 10 CFR 
Part 20; (2) the internal dose assessment recommended by the 
International Commission on Radiological Protection (ICRP), Publication 
30, ``Limits for Intakes of Radionuclides by Workers''; and (3) the 
recommended bioassay interpretation method by ICRP Publication 54, 
``Individual Monitoring for Intakes of Radionuclides by Workers: Design 
and Interpretation.''
    Regulatory Guide, 8.22, Revision 2 also provides: (1) 
Recommendations based on the nephrotoxic analyses in NUREG-0874, 
``Internal Dosimetry Model for Applications to Bioassay at Uranium 
Mills,'' (Appendix A of the guide); and (2) the consensus standard of 
the American National Standards Institute/Health Physics Society (ANSI/
HPS) N13.30-2011, ``Performance Criteria for Radiobioassay,'' that is 
applicable for uranium mills.

III. Congressional Review Act

    This RG is a rule as defined in the Congressional Review Act (5 
U.S.C. 801-808). However, the Office of Management and Budget has not 
found it to be a major rule as defined in the Congressional Review Act.

[[Page 35388]]

IV. Backfitting and Issue Finality

    Issuance of this final RG does not constitute backfitting as 
defined in 10 CFR 50.109, 70.76, 72.62, or 76.76 and is not otherwise 
inconsistent with the issue finality provisions in 10 CFR Part 52, 
``Licenses, Certifications, and Approvals for Nuclear Power Plants.'' 
This final RG provides guidance to applicants for, and holders of, 
uranium milling licenses and some uranium conversion facility licenses 
on methods for meeting certain NRC regulatory requirements for 
bioassays in 10 CFR Part 20.
    Licensees may voluntarily use RG 8.22, Revision 2 to demonstrate 
compliance with the underlying NRC's regulations.

    Dated at Rockville, Maryland, this 17th day of June, 2014.

    For the Nuclear Regulatory Commission.
Thomas H. Boyce,
 Chief, Regulatory Guidance and Generic Issues Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2014-14452 Filed 6-19-14; 8:45 am]
BILLING CODE 7590-01-P